UK health system, under strain, lays out medtech strategy

The state-run National Health Service, now facing a strike by nurses and paramedics, hopes new technologies will help solve some of its long-term challenges to improve patient care.

By Susan Kelly • Feb. 7, 2023

Diagnostic firms turn to restructuring in bid to preserve cash: Goldman

The moves could lead to underfunding, delay or cancellation of research and development projects, the analysts say.

By Nick Paul Taylor • Feb. 7, 2023

Explore the Trendline➔

Medical device industry continues to turn to digital health, AI

While the industry continues to embrace digital health and artificial intelligence, there are still questions about how the new technologies and services need to be regulated and if they are effective.

By MedTech Dive staff

Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023

Still, the latest round of quarterly results show that hospital staffing and supply chain remain a challenge.

By Nick Paul Taylor • Feb. 6, 2023

Quest cuts 2023 COVID tests forecast amid continued slump in demand; Q4 profit plunges

The company performed 1.2 million molecular tests in the fourth quarter, down from 1.9 million in the third quarter and 5.4 million one year ago.

By Nick Paul Taylor • Feb. 3, 2023

Friday Q&A: Medtronic’s Chan talks patient monitoring spinoff, rise of home care

As more patients are moved out of expensive hospital beds, Medtronic sees a growing market for remote care in homes and long-term care facilities.

By Elise Reuter • Feb. 2, 2023

BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables

The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.

By Susan Kelly • Feb. 2, 2023

Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes

Lower diagnostics revenue hurt sales in the three months ended Dec. 31.

By Nick Paul Taylor • Feb. 2, 2023

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.

By Peter Green • Jan. 31, 2023

Researchers create remote-controlled biological robot that could eventually be used in surgery

The design allows the integration of sensors and other components that could eventually equip the robots to detect biomarkers of disease, carry out biopsies or perform surgery.

By Nick Paul Taylor • Jan. 26, 2023

Abbott sees ‘signs of stability’ for 2023 as hospital staffing, supply chain improves

While the company continues to grapple with supply shortages and procedure restrictions, it sold more COVID-19 tests than expected in the fourth quarter.

By Elise Reuter • Jan. 25, 2023

FDA weighs shift in COVID vaccination strategy

Agency scientists are proposing to update COVID shots once a year to match circulating coronavirus strains, as well as simplifying current vaccination regimens.

By Ned Pagliarulo • Jan. 23, 2023

3 questions for Michael Snyder, lead inventor of single-drop blood test

The head of a Stanford research team says the test differs from Theranos' defunct product because "ours works."

By Peter Green • Jan. 23, 2023

Stanford team reports progress with Theranos-like finger prick blood test

The researchers have created a system for capturing and analyzing thousands of molecules from a single drop of blood.

By Nick Paul Taylor • Jan. 23, 2023

Realizing the promise of AI for medical imaging and diagnosis

Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud, explains how medtech companies can benefit from applying AI to the explosion of medical imaging data.

By Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud • Jan. 19, 2023

CT scans offer new path to diagnose treatable cause of high blood pressure, study shows

While the approach could increase demand for CT imaging, the supply of radioactive tracers is potentially a barrier to adoption of the technique.

By Nick Paul Taylor • Jan. 19, 2023

Deep learning may improve triaging of people with acute chest pain, study shows

The researchers trained a model to find signs in scans that a person may have a serious cardiovascular condition.

By Nick Paul Taylor • Jan. 19, 2023

Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy

Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.

By Elise Reuter • Updated Jan. 18, 2023

AI predicts lung cancer risk six years into the future using single CT scan: study

A research team has made the deep learning model publicly available and says it has no intention to commercialize it.

By Nick Paul Taylor • Jan. 17, 2023

Cue Health lays off 388 people as demand falls for COVID-19 tests

Cue is reducing its headcount by 26% after laying off 170 employees last June. 

By Nick Paul Taylor • Jan. 11, 2023

Guardant Health posts revenue growth in Q4 on higher clinical testing volumes

The oncology diagnostics company’s preliminary results beat analyst estimates.

By Nick Paul Taylor • Jan. 10, 2023

Labcorp hires ex-Quintiles CEO to lead clinical development unit ahead of upcoming spinoff

Thomas Pike, who oversaw the transformational merger of Quintiles and IMS Health, will be in charge of a CRO for the first time since 2016.

By Nick Paul Taylor • Jan. 6, 2023

AstraZeneca extends C2i pact to validate minimal residual disease solid tumor blood test

The technology could improve cancer treatment and support clinical trial recruitment and monitoring.

By Nick Paul Taylor • Jan. 6, 2023

Illumina signs new $750M credit agreement after bumpy year

The fallout from Illumina’s takeover of Grail and macroeconomic challenges have weighed on the company’s share price, which has fallen about 45% in the past 12 months.

By Nick Paul Taylor • Jan. 5, 2023

Roche receives first European IVDR certificate for companion diagnostic

Receipt of the certificate clears Roche to sell a companion diagnostic for immune checkpoint inhibitors in the European Union.

By Nick Paul Taylor • Jan. 5, 2023

GE HealthCare starts trading on Nasdaq as independent company

The company’s stock gained in morning trading after debuting at $56 per share.

By Elise Reuter • Jan. 4, 2023